logo
episode-header-image
Nov 2021
44m 37s

Updates in Chronic Spontaneous Urticaria...

MEDSCAPE PODCASTS
About this episode

Learn about the pathophysiology of CSU and latest data with novel agents presented at EADV 2021.

Credit available for this activity expires: 11/30/2022

Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963626?src=mkm_podcast_addon_963626

Up next
Jun 30
Pharmacological and Combination Interventions for Nicotine Cessation
Master the latest evidence-based meds and dual therapies to help your patients quit for good. Credit available for this activity expires: 06/25/2027 Earn Credit / Learning Objectives & Disclosures: https://www.staging.medscape.org/viewarticle/pharmacological-and-combination-inter ... Show More
33m 24s
Jun 26
Is Normalizing Hemostasis an Achievable Goal in Hemophilia A?
Is sustained hemostatic normalization achievable across all hemophilia A patients? Examine the evidence behind today's therapeutic advances. Credit available for this activity expires: 6/26/27 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/n ... Show More
29m 31s
Jun 26
The Top 5 Errors in Transthyretin Amyloid Cardiomyopathy Management
Drs García-Pavia and Sperry break down the top 5 mistakes in transthyretin amyloid cardiomyopathy (ATTR-CM) management and share clinical solutions for earlier, optimized patient care. Credit available for this activity expires: 6/25/27 Earn Credit / Learning Objectives & Disclos ... Show More
17m 41s
Recommended Episodes
Dec 2021
Hot Topics in Atrial Fibrillation
Listen in as experts discuss the latest updates in AFib management. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/963752?src=mkm_podcast_addon_963752 
14m 43s
Jun 2024
EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Lea ... Show More
33m 47s
Apr 2025
Milestones in IgAN & FSGS: Advancing Understanding and Possibilities
Join us for an insightful podcast exploring the latest milestones in the understanding and treatment of IgA nephropathy (IgAN) and focal segmental glomerulosclerosis (FSGS). Discover how recent breakthroughs in our understanding of these conditions are advancing clinical research ... Show More
35m 30s
Nov 2021
E44: Editor’s Picks November 2021
Join us as we go through the JEADV Editor's Picks of November 2021: (1) Long-term safety data for a monoclonal antibody used in psoriasis (2) Preventing anaphylactoid symptoms following Covid-19 vaccination (3) Innovative surgery option for bromhidrosis (4) Surprising trends in s ... Show More
10m 31s
Oct 2025
Komal Jhaveri, MD, FACP - Visual Exploration of the Evolving Role of Novel Oral SERDs, Other ER-Targeting Therapies, and Rational Combinations in ER+, HER2- MBC
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups.For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC/NCPD/CPE/AAPA/IPCE i ... Show More
41m 33s
Jan 2022
#319 Hotcakes: Afib, Chlorthalidone in CKD, Outpatient COVID Treatment Update
Fill up your plate with a fresh stack of 2022 hotcakes! Drs. Paul Williams (@PaulNWilliamz), Rahul Ganatra (@rbganatra), Nora Taranto (@NoraTaranto), and Matt Watto help catch us up recent practice-changing articles and guidelines including patient-directed interventions in atria ... Show More
44m 52s
Jan 2025
2025 Retina Update, Part 1: Injectables in the Medical Retina Space
Drs. Ashkan Abbey and Ehsan Rahimy join host Dr. Jay Sridhar to discuss recent developments in the medical retina and injectable space, including faricimab versus high-dose aflibercept, biosimilars for ranibizumab and aflibercept, off-label bevacaziumb shortages, dry age-related ... Show More
43m 39s
Dec 2021
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Nov. 29, Part 2)
This episode of Eagle’s Eye View examines the long-term outcomes for patients with left main CAD treated with PCI with drug-eluting stents vs. CABG; a state-of-the-art review on acute aortic syndrome; and the impact of heart disease subtypes on in-hospital mortality of patients w ... Show More
9m 15s
Jan 2022
OTA 2021 Annual Meeting Notable Paper P62 - A Prospective Randomized Controlled Trial Comparing Subcutaneous Enoxaparin & Oral Rivaroxaban for Venous Thromboembolism Prophylaxis in Orthopaedic Trauma Patients
Join host Dr. Paul Whiting as he interviews paper authors Drs. Hassan Mir and Mitchell John as they discuss the Notable Paper on treatment of venous thromboembolism. This paper was presented at the OTA 2021 Annual Meeting. For additional educational resources visit https://ota.or ... Show More
10m 59s
Jul 2022
Ep 171 Posterior Stroke, EP Lead, HEAR Score, Ketamine for Suicidal Ideation, Peer Support Workers – Highlights from Calgary EM Hodsman Lecture Day
In this special edition main EM Cases podcast episode we feature the highlights from live podcasts recorded at Calgary EM during their annual Hodsman Lecture Day, covering a variety of current EM topics: The challenges of posterior circulation stroke (PCIS); Emergency Physician L ... Show More
1h 59m